Health Economics Archives

11/02/2021

4 roadblocks facing orphan medicines seeking to achieve market access in Europe - Economic evidence development

Challenges for orphan medicines entering the European market – Part 3: Economic evidence development

By Inês Tenente | Evidence, Global Market Access, Health Economics | No Comments

In this four-part series, Ines Tenente (Senior Consultant – Global Market Access) explores the various challenges facing orphan medicines entering the European market and suggests solutions that can help improve patient...

27/01/2021

How health economic modelling can help MedTech innovations reach patients – an interview with Calum Jones

By Calum Jones | Health Economics, MedTech | No Comments

Calum Jones, Consultant Health Economist at Mtech Access, shares his passion for helping MedTech firms build health economic models that help their innovative new technologies reach patients. Tell us about...

18/09/2019

Should NICE consider a broader societal perspective when assessing new gene therapies?

By Lily Sanders | Health Economics | No Comments

Dan Howard and Hannah Gillies from our Health Economics team explore some of the themes from a recent Health Affairs Blog article on the implications of new cell and gene therapies on HTA: ‘Putting The Costs And...

Want to find out more? Get in touch

Office Hours (GMT)

Monday	09:00 – 18:00
Tuesday	09:00 – 18:00
Wednesday	09:00 – 18:00
Thursday	09:00 – 18:00
Friday	09:00 – 18:00
Saturday	Closed
Sunday	Closed

Health Economics

Challenges for orphan medicines entering the European market – Part 3: Economic evidence development

How health economic modelling can help MedTech innovations reach patients – an interview with Calum Jones

Should NICE consider a broader societal perspective when assessing new gene therapies?

Insights Newsletter

Recent Posts

Archives

Categories

Company Information

Registed Address

Contact Information

Office Hours (GMT)

Mtech Demo Portal